Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm
ClinicalTrials.gov ID
NCT02120066
Lead Sponsor
Kyorin UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
22Actual
Last Update Posted
Apr 22, 2014Estimated
Start Date
Jan 2011
Primary Completion Date
Jun 2013Actual
Completion Date
Apr 2014Actual
Brief Summary
Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.
Submacular Hemorrhage
Ruptured Retinal Arterial Macro Aneurysms
Vitrectomy for submacular hemorrhage
subretinal injection of tissue-plasminogen activator
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms
Exclusion Criteria:
The eyes with preretinal or intraretinal hemorrhage at the fovea